DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans
by Press Release from Outbreak News Today on (#344VC)
A new generation DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans, according to new research from the Perelman School of Medicine at the University of Pennsylvania, conducted in partnership with The Wistar Institute, Inovio Pharmaceuticals, and GeneOne Life Science, Inc. In ["]
The post DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans appeared first on Outbreak News Today.